How RWD and AI Can Accelerate Drug Development for Common Cancers: Q&A with Dr. C.K. Wang
As incidence rates for many common cancers continue to rise – breast, prostate, colorectal, pancreatic, and others – life sciences teams need high-quality cancer real-world data (RWD) to power their research and help develop lifesaving treatments. Building on our expertise in curating RWD for hematologic cancers, which are blood-based cancers such as multiple myeloma, COTA […]
